GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (FRA:D6M) » Definitions » Research & Development

Genedrive (FRA:D6M) Research & Development : €4.90 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Genedrive Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Genedrive's Research & Development for the six months ended in Jun. 2024 was €2.72 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was €4.90 Mil.

Genedrive Research & Development Historical Data

The historical data trend for Genedrive's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genedrive Research & Development Chart

Genedrive Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.19 5.25 4.51 4.57 4.94

Genedrive Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.26 2.29 2.26 2.18 2.72

Genedrive Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genedrive  (FRA:D6M) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Genedrive Research & Development Related Terms

Thank you for viewing the detailed overview of Genedrive's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Genedrive Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (FRA:D6M) » Definitions » Research & Development
Comparable Companies
LSE:PRM LSE:VRCI LSE:ABDX LSE:GENI LSE:LLAI LSE:AGL TMO DHR XSWX:LONN A IDXX IQV SHSE:603259 MTD WAT NTRA LH DGX ICLR ILMN
Traded in Other Exchanges
GDR:UK
Address
Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX
Website
http://www.genedriveplc.com
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom and also has its presence in Europe, United States of America and Rest of the World.

Genedrive Headlines

No Headlines